Boston Scientific Reports Q3 EPS of $0.40
Story updates
10:31:57 AM UTC
SquawkNews
Boston Scientific reported Q3 2026 net sales of $5.138B, GAAP EPS $0.40 and adjusted EPS $0.73. It now guides FY26 sales growth ~4.25% reported (~3.75% organic) and adjusted EPS $3.16—$3.18; Q4 sales seen down ~1% to 3% with adjusted EPS $0.77—$0.79.Material DetailsContext by AI AnalystThis is a mi…
10:43:30 AM UTC
SquawkNews
Boston Scientific reported third-quarter 2026 net sales of $5.138 billion, up 1.5% year over year, and GAAP net income attributable to common stockholders of $582 million, or $0.40 per diluted share. Adjusted EPS was $0.73, compared with $0.75 a year earlier. The company lowered its full-year 2026…